Stehlik amp Dorfleutner Lab Cedars Sinai

Stehlik amp Dorfleutner Lab Cedars Sinai

Stehlik & Dorfleutner Lab Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog English English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Translation is unavailable for Internet Explorer Cedars-Sinai Home 1-800-CEDARS-1 1-800-CEDARS-1 Close Find a Doctor Locations Programs & Services Health Library Patient & Visitors Community My CS-Link RESEARCH clear Go Close Navigation Links Academics Faculty Development Community Engagement Calendar Research Research Areas Research Labs Departments & Institutes Find Clinical Trials Research Cores Research Administration Basic Science Research Clinical & Translational Research Center (CTRC) Technology & Innovations News & Breakthroughs Education Graduate Medical Education Continuing Medical Education Graduate School of Biomedical Sciences Professional Training Programs Medical Students Campus Life Office of the Dean Simulation Center Medical Library Program in the History of Medicine About Us All Education Programs Departments & Institutes Faculty Directory Stehlik & Dorfleutner Lab The collaborative Stehlik and Dorfleutner Laboratory of molecular innate immunology employs a team-based approach to the science of studying the mechanisms of innate immune responses in health and disease. Phagocytic immune cells (such as monocytes, macrophages and dendritic cells) encode cytosolic pattern recognition receptors (including Nod-like receptors, absent in melanoma 2-like receptors and pyrin) that sense danger signals and pathogens. Their activation leads to the assembly of the inflammasome complex, which is responsible for the processing and release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18, which in turn recruit and activate innate immune cells. While acute, localized and temporary inflammation is beneficial and contributes to pathogen clearance, wound healing and tissue repair, chronic and inappropriate inflammation is linked to tissue destruction and inflammatory and immune disease. Therefore, an important goal of our studies is to define strategies to limit these excessive and uncontrolled inflammatory responses to provide novel avenues for therapeutic intervention. The Stehlik and Dorfleutner Laboratory is affiliated with the Cedars-Sinai Department of Pathology and Laboratory Medicine, Department of Biomedical Sciences and the Samuel Oschin Comprehensive Cancer Institute. Personal Statement "The Stehlik and Dorfleutner Laboratory utilizes leading-edge molecular, cellular and in vivo approaches for research in the field of molecular innate immunology with the goal to elucidate novel immune-regulatory mechanisms to advance our understanding of human immunity, and to identify novel targets for developing future therapies." Andrea Dorfleutner PhD, MS Christian Stehlik PhD, MS Breakthrough Research Areas Discovery and functional characterization of the PYRIN domain-only protein family of human inflammasome inhibitors and their role in ameliorating inflammatory disease Identification of the human NLRP7 inflammasome Discovery of non-canonical inflammasome regulation Tonic type I interferon-mediated maintenance of intestinal homeostasis and microbial diversity Meet Our Team Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Stehlik and Dorfleutner Laboratory, whose dedicated efforts lead to groundbreaking discoveries. View Our Team Publications The oxidized phospholipid oxPAPC protects from septic shock by targeting non-canonical inflammasome in macrophages. Chu HL, Indramohan M, Ratsaimandresy RA, Gangopadhyay A, Morris EP, Monack DM, Dorfleutner A*, Stehlik C*. Nat Commun. 2018 Mar 8;9(1):996. The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease. de Almeida L, Khare S, Misharin AV, Patel R, Wallin M, Perlman HR, Greaves DR, Hoffman HM, Dorfleutner A*, Stehlik C*. Immunity. 2015 Aug 18;43(2):264-276. The PYRIN domain-only protein POP3 inhibits AIM2-like receptor inflammasomes and regulates responses to DNA virus infections. Khare S, Ratsimandresy RA, de Almeida L, Cuda CM, Rellick SL, Misharin AV, Wallin MC, Gangopadhyay A, Forte E, Gottwein E, Perlman H, Reed JC, Greaves DR, Dorfleutner A*, Stehlik C*. Nat Immunol. 2014 Apr;15(4):343-353. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Khare S, Dorfleutner A, Bryan NB, Yun C, Radian AD, de Almeida L, Rojanasakul Y, Stehlik C. Immunity. 2012 Mar 23;36(3):464-476. Contact the Stehlik & Dorfleutner Lab 127 S. San Vicente Blvd. Pavilion, Room A-8700 Los Angeles, CA 90048 310-967-0614 Christian Stehlik PhD Send a Message Andrea Dorfleutner PhD Send a Message Please ensure Javascript is enabled for purposes of website accessibility
Share:
0 comments

Comments (0)

Leave a Comment

Minimum 10 characters required

* All fields are required. Comments are moderated before appearing.

No comments yet. Be the first to comment!